Viewing nowCombinationMaxmica Tablets 80/5 mg
Telmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Albozen Korea Co., Ltd.

MFDS item code 201605860 · Approved 2016.09.30 · Insurance code 652606280
Treatment of essential hypertension not controlled with monotherapy
This medication helps effectively lower blood pressure in patients with essential hypertension who find it difficult to control their blood pressure with amlodipine or telmisartan monotherapy. Essential hypertension is a condition where blood pressure frequently rises, potentially increasing the risk of cardiovascular diseases. This drug stabilizes blood pressure by dilating blood vessels or regulating blood pressure. If blood pressure is not adequately controlled, using this medication can assist in managing blood pressure and preventing complications. Therefore, this medication is used in the treatment of essential hypertension.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. If possible, it is recommended that it be taken at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not adequately controlled with the individual components as follows, switching directly to this medicine may be considered. - 40/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or telmisartan 40mg. - 80/5mg: For patients whose blood pressure is not adequately controlled with amlodipine 5mg or this medicine 40/5mg. - 40/10mg: For patients whose blood pressure is not adequately controlled with amlodipine 10mg. ○ Patients with renal impairment: No dose adjustment is necessary in patients with mild or moderate renal impairment. For patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment: The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Older adults: The usual amlodipine dosage regimen is recommended for older adults, but caution should be exercised when increasing the dose (see section ‘3. Patients who should use this medicine with caution’). In older adults aged 75 years or older, amlodipine clearance is reduced; therefore, treatment should be started at a low dose and the dose increased gradually.
○ Children: This medicine is not recommended for pediatric patients 18 years of age or younger because its safety and efficacy have not been established.
This drug can cause serious harm to the fetus, especially during the second and third trimesters, so it should not be taken by pregnant women or women who may become pregnant. This drug should not be given to patients with allergies to the active ingredients or with severe liver impairment, severe hypotension, or heart-related problems. Patients with compromised liver function or gastrointestinal disorders, or those with kidney issues should use this medication with caution and regularly monitor their blood pressure or kidney function. Side effects, such as dizziness or edema may occur while taking this drug; if unusual symptoms arise, consult a doctor. As blood pressure may drop too low, special care should be taken during the initial dose; if hypotensive symptoms appear, immediately lie down and rest, and seek medical attention if necessary. Since potassium levels may increase, caution is needed when taking this drug with potassium-rich foods or potassium supplements and certain diuretics. This medication may interact with other blood pressure medications and specific drugs, so if you are taking other medications, you must inform your doctor or pharmacist. It is advisable for breastfeeding women to avoid this medication, and it should be avoided during pregnancy planning or while pregnant. Safety and efficacy in children have not been established, hence it is not recommended for pediatric use. Elderly patients may be more sensitive to the drug, requiring cautious dosage adjustments and monitoring. In case of overdose, severe hypotension or cardiac problems may occur, so immediate hospital treatment is necessary. Keep this medication out of the reach of children and store it in its original packaging.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a container protected from light and air, at room temperature between 1°C and 30°C. This storage condition helps maintain the medication's efficacy and prevent deterioration.
White to pale yellow and light blue, oval-shaped, double-coated tablet with a biconvex surface
30 tablets (10 tablets/PTP × 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Albozen Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 40mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
ILDONG Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
CombinationTelmisartan 80mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Ildong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.